RT Book, Section A1 Murri, PharmD, MBA, Nelda A2 Brunton, Laurence L. A2 Knollmann, Björn C. SR Print(0) ID 1198878305 T1 The Goodman & Gilman Year in Review: 2017 New and Noteworthy FDA Approvals T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition YR 2023 FD 2023 PB McGraw-Hill Education PP New York, NY SN 9781264258079 LK accessanesthesiology.mhmedical.com/content.aspx?aid=1198878305 RD 2024/03/29 AB In 2017 the U.S. Food and Drug Administration (FDA) approved 40 new drugs and granted 48 noteworthy biologic licenses. The 40 new drugs are cataloged in Part 1. Among them are: